BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17874347)

  • 1. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.
    Haberfellner EM
    Pharmacopsychiatry; 2007 Sep; 40(5):173-82. PubMed ID: 17874347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy, tolerability, and safety of contemporary antidepressants.
    Papakostas GI
    J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation strategies to increase antidepressant tolerability.
    Zajecka JM
    J Clin Psychiatry; 2007; 68 Suppl 10():23-7. PubMed ID: 17900206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and sexual dysfunction.
    Werneke U; Northey S; Bhugra D
    Acta Psychiatr Scand; 2006 Dec; 114(6):384-97. PubMed ID: 17087787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.
    Bonierbale M; Lançon C; Tignol J
    Curr Med Res Opin; 2003; 19(2):114-24. PubMed ID: 12740155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant drug therapy and sexual dysfunction in men: a review.
    Mitchell JE; Popkin MK
    J Clin Psychopharmacol; 1983 Apr; 3(2):76-9. PubMed ID: 6341418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
    Pae CU; Marks DM; Masand PS; Peindl K; Hooper-Wood C; Han C; Mannelli P; Ciccone P; Patkar AA
    Clin Neuropharmacol; 2009; 32(2):85-8. PubMed ID: 19512961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials.
    Khin NA; Kronstein PD; Yang P; Ishida E; Hung HM; Mathis MV; Unger EF; Temple RJ
    J Clin Psychiatry; 2015 Aug; 76(8):1060-3. PubMed ID: 26214346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants.
    Balon R; Segraves RT
    J Sex Marital Ther; 2008; 34(4):353-65. PubMed ID: 18576236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dysfunction associated with major depressive disorder and antidepressant treatment.
    Clayton AH; El Haddad S; Iluonakhamhe JP; Ponce Martinez C; Schuck AE
    Expert Opin Drug Saf; 2014 Oct; 13(10):1361-74. PubMed ID: 25148932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major depressive disorder, antidepressants, and sexual dysfunction.
    Clayton AH; Montejo AL
    J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female sexual dysfunction related to depression and antidepressant medications.
    Clayton AH
    Curr Womens Health Rep; 2002 Jun; 2(3):182-7. PubMed ID: 12099193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant medication on sexual function: a controlled study.
    Harrison WM; Rabkin JG; Ehrhardt AA; Stewart JW; McGrath PJ; Ross D; Quitkin FM
    J Clin Psychopharmacol; 1986 Jun; 6(3):144-9. PubMed ID: 3711364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression and sexual dysfunction: aspects of a multi-faceted relationship].
    Hartmann U
    Psychiatr Prax; 2007 Sep; 34 Suppl 3():S314-7. PubMed ID: 17786891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bupropion on sexual dysfunction.
    Ginzburg R; Wong Y; Fader JS
    Ann Pharmacother; 2005 Dec; 39(12):2096-9. PubMed ID: 16288071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan.
    Chen KC; Yang YK; Lee IH; Yeh TL; Lu RB; Chen PS
    Depress Anxiety; 2008; 25(9):E56-62. PubMed ID: 17551923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction.
    Morehouse R; Macqueen G; Kennedy SH
    J Affect Disord; 2011 Aug; 132 Suppl 1():S14-20. PubMed ID: 21575992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.